BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:FWY003 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of FWY003\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07441642-11255@assetmemo.bio
DTSTAMP:20261121T005617Z
DTSTART;VALUE=DATE:20290821
DTEND;VALUE=DATE:20290822
SUMMARY:FWY003: Phase 2 readout est. (NCT07441642)
DESCRIPTION:FWY003\, phase 2\, Geographic Atrophy.\nStudy: A Study to Inves
 tigate Efficacy and Safety of FWY003 Compared With Placebo in Participants
  With Geographic Atrophy Secondary to Age-related Macular Degeneration\nEs
 timated primary completion: 21 August 2029. This is a ClinicalTrials.gov e
 stimate\, not a confirmed readout date\, and it can move.\nDrug page: http
 s://assetmemo.bio/drug/fwy003#upcoming-events\nRegistry record: https://cl
 inicaltrials.gov/study/NCT07441642
URL:https://assetmemo.bio/drug/fwy003#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
